Mono Pharmacare Limited
ListedSMEHealthcare · NSE
Incorporated in 1994, Mono Pharmacare Limited is engaged in the marketing and distribution of pharmaceutical products, offering a wide range of medicines and healthcare items including antibiotics, allergy & cough medicines, antifungals, nutraceuticals, pain relievers, antacids, antiemetics, and cardiac-diabetic medicines, along with cosmocare products. The company sells products under its brand “DLS Export”, which it acquired in 2022 for ₹609 lakhs to expand its product portfolio. As of February 28, 2023, Mono Pharmacare works with more than 168 pharmaceutical distributors & stockists and serves over 3,036 customers across retail pharmacy stores and wholesalers.
Price Band
₹26 – ₹28
Issue Size
₹14.84 Cr
Lot Size
4000 shares
GMP
₹2
+7.1%
Est. Listing
₹30
at current GMP
Subscribed
13.47x
overall
Open
28 Aug 2023
Close
30 Aug 2023
Allotment
4 Sep 2023
Refund
5 Sep 2023
Demat Credit
6 Sep 2023
Listing
7 Sep 2023
Last updated 12 days ago
Key Highlights
- •Leading player in the Healthcare segment
- •Price band established at ₹26 - ₹28 per equity share
- •Minimum bid lot is 4000 shares
- •Estimated listing target of ₹30 based on current grey market activity